Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Table of Contents

June 01, 2022; Volume 50,Issue 6

Special Section on Pharmacokinetics and ADME of Biological Therapeutics

  • You have access
    Special Section on Pharmacokinetics and ADME of Biological Therapeutics–Editorial
    Yurong Lai and Xiao-bo Zhong
    Drug Metabolism and Disposition June 2022, 50 (6) 819-821; DOI: https://doi.org/10.1124/dmd.122.000896
  • Augmented Clearance of Nivolumab Is Associated with Renal Functions in Chronic Renal Disease Model Rats
    You have access
    Augmented Clearance of Nivolumab Is Associated with Renal Functions in Chronic Renal Disease Model Rats
    Kazuaki Taguchi, Yukitaka Hayashi, Mayu Ohuchi, Hotaka Yamada, Shigehiro Yagishita, Yuki Enoki, Kazuaki Matsumoto and Akinobu Hamada
    Drug Metabolism and Disposition June 2022, 50 (6) 822-826; DOI: https://doi.org/10.1124/dmd.121.000520
  • You have access
    The In Vivo Pharmacokinetics of Block Copolymers Containing Polyethylene Glycol Used in Nanocarrier Drug Delivery Systems
    Lei Yin, Yiling Pang, Lin Shan and Jingkai Gu
    Drug Metabolism and Disposition June 2022, 50 (6) 827-836; DOI: https://doi.org/10.1124/dmd.121.000568
  • You have access
    Absorption, Distribution, Metabolism, and Excretion of Therapeutic Proteins: Current Industry Practices and Future Perspectives
    Jayaprakasam Bolleddula, Kevin Brady, Gerard Bruin, Anthony Lee, Jennifer A. Martin, Markus Walles, Keyang Xu, Tong-Yuan Yang, Xiaochun Zhu and Hongbin Yu
    Drug Metabolism and Disposition June 2022, 50 (6) 837-845; DOI: https://doi.org/10.1124/dmd.121.000461
  • You have access
    A Cross Company Perspective on the Assessment of Therapeutic Protein Biotransformation
    Markus Walles, Michael Berna, Wenying Jian, Simon Hauri, Shawna Hengel, Lloyd King, John C. Tran, Cong Wei, Keyang Xu and Xiaochun Zhu
    Drug Metabolism and Disposition June 2022, 50 (6) 846-857; DOI: https://doi.org/10.1124/dmd.121.000462
  • You have access
    Characterizing the Pharmacokinetics and Biodistribution of Therapeutic Proteins: An Industry White Paper
    Kathryn Ball, Gerard Bruin, Enrique Escandón, Christoph Funk, Joao N.S. Pereira, Tong-Yuan Yang and Hongbin Yu
    Drug Metabolism and Disposition June 2022, 50 (6) 858-866; DOI: https://doi.org/10.1124/dmd.121.000463
  • You have access
    Mathematical Models to Characterize the Absorption, Distribution, Metabolism, and Excretion of Protein Therapeutics
    Shufang Liu and Dhaval K. Shah
    Drug Metabolism and Disposition June 2022, 50 (6) 867-878; DOI: https://doi.org/10.1124/dmd.121.000460
  • You have access
    Adverse Drug Reactions and Toxicity of the Food and Drug Administration–Approved Antisense Oligonucleotide Drugs
    Feryal Alhamadani, Kristy Zhang, Rajvi Parikh, Hangyu Wu, Theodore P. Rasmussen, Raman Bahal, Xiao-bo Zhong and José E. Manautou
    Drug Metabolism and Disposition June 2022, 50 (6) 879-887; DOI: https://doi.org/10.1124/dmd.121.000418
  • You have access
    Absorption, Distribution, Metabolism, and Excretion of US Food and Drug Administration–Approved Antisense Oligonucleotide Drugs
    Julia M. Migliorati, Sunna Liu, Anna Liu, Anagha Gogate, Sreenidhi Nair, Raman Bahal, Theodore P. Rasmussen, José E. Manautou and Xiao-bo Zhong
    Drug Metabolism and Disposition June 2022, 50 (6) 888-897; DOI: https://doi.org/10.1124/dmd.121.000417

Minireview

  • The Nonclinical Disposition and Pharmacokinetic/Pharmacodynamic Properties of <em>N</em>-Acetylgalactosamine–Conjugated Small Interfering RNA Are Highly Predictable and Build Confidence in Translation to Human
    Open Access
    The Nonclinical Disposition and Pharmacokinetic/Pharmacodynamic Properties of N-Acetylgalactosamine–Conjugated Small Interfering RNA Are Highly Predictable and Build Confidence in Translation to Human
    Robin McDougall, Diane Ramsden, Sagar Agarwal, Saket Agarwal, Krishna Aluri, Michael Arciprete, Christopher Brown, Elena Castellanos-Rizaldos, Klaus Charisse, Saeho Chong, Joseph Cichocki, Kevin Fitzgerald, Varun Goel, Yongli Gu, Dale Guenther, Bahru Habtemariam, Vasant Jadhav, Maja Janas, Muthusamy Jayaraman, Jeffrey Kurz, Jing Li, Ju Liu, Xiumin Liu, Steven Liou, Chris Maclauchlin, Martin Maier, Muthiah Manoharan, Jayaprakash K. Nair, Gabriel Robbie, Karyn Schmidt, Peter Smith, Christopher Theile, Akshay Vaishnaw, Scott Waldron, Yuanxin Xu, Xuemei Zhang, Ivan Zlatev and Jing-Tao Wu
    Drug Metabolism and Disposition June 2022, 50 (6) 781-797; DOI: https://doi.org/10.1124/dmd.121.000428

Articles

  • You have access
    Characterizing and Quantifying Extrahepatic Metabolism of (−)-Δ9-Tetrahydrocannabinol (THC) and Its Psychoactive Metabolite, (±)-11-Hydroxy-Δ9-THC (11-OH-THC)
    Aditya R. Kumar, Gabriela I. Patilea-Vrana, Olena Anoshchenko and Jashvant D. Unadkat
    Drug Metabolism and Disposition June 2022, 50 (6) 734-740; DOI: https://doi.org/10.1124/dmd.122.000868
  • You have access
    Reevaluate In Vitro CYP3A Index Reactions of Benzodiazepines and Steroids between Humans and Dogs
    QingLiang Wu, YiTing Hu, CuiTong Wang, Wei Wei, LanLan Gui, WuShuang Zeng, Changxiao Liu, Wei Jia, Jia Miao and Ke Lan
    Drug Metabolism and Disposition June 2022, 50 (6) 741-749; DOI: https://doi.org/10.1124/dmd.122.000864
  • You have access
    Predicting Impact of Food and Feeding Time on Oral Absorption of Drugs with a Novel Rat Continuous Intestinal Absorption Model
    Casey Radice, Ken Korzekwa and Swati Nagar
    Drug Metabolism and Disposition June 2022, 50 (6) 750-761; DOI: https://doi.org/10.1124/dmd.122.000831
  • You have access
    Label-Free but Still Constrained: Assessment of Global Proteomic Strategies for the Quantification of Hepatic Enzymes and Transporters
    Jill Barber, Zubida M. Al-Majdoub, Narciso Couto, Areti-Maria Vasilogianni, Annika Tillmann, Sarah Alrubia, Amin Rostami-Hodjegan and Brahim Achour
    Drug Metabolism and Disposition June 2022, 50 (6) 762-769; DOI: https://doi.org/10.1124/dmd.121.000780
  • You have access
    Localization of Xenobiotic Transporters Expressed at the Human Blood-Testis Barrier
    Raymond K. Hau, Robert R. Klein, Stephen H. Wright and Nathan J. Cherrington
    Drug Metabolism and Disposition June 2022, 50 (6) 770-780; DOI: https://doi.org/10.1124/dmd.121.000748
  • You have access
    Pharmacokinetics, Mass Balance, and Metabolism of the Novel Urate Transporter 1 Inhibitor [14C]HR011303 in Humans: Metabolism Is Mediated Predominantly by UDP-Glucuronosyltransferase
    Yuandong Zheng, Hua Zhang, Mengling Liu, Guangze Li, Sheng Ma, Zhe Zhang, Hongda Lin, Yan Zhan, Zhendong Chen, Dafang Zhong, Liyan Miao and Xingxing Diao
    Drug Metabolism and Disposition June 2022, 50 (6) 798-808; DOI: https://doi.org/10.1124/dmd.121.000581
  • You have access
    Mechanistic Study on the Species Differences in Excretion Pathway of HR011303 in Humans and Rats
    Zitao Guo, Mengling Liu, Jian Meng, Yaru Xue, Qi Huang, Yuandong Zheng, Yali Wu, Zhendong Chen, Jinghua Yu, Dafang Zhong, Guangze Li, Xiaoyan Chen and Xingxing Diao
    Drug Metabolism and Disposition June 2022, 50 (6) 809-818; DOI: https://doi.org/10.1124/dmd.121.000582
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition: 50 (6)
Drug Metabolism and Disposition
Vol. 50, Issue 6
1 Jun 2022
  • Table of Contents
  • About the Cover
  • Index by author
Sign up for alerts

Jump to

  • Special Section on Pharmacokinetics and ADME of Biological Therapeutics
  • Minireview
  • Articles
  • Most Read
Loading
  • Cannabinoid Metabolites as CYP450 Inhibitors
  • Physiology of the Neonatal Gastrointestinal System
  • Pharmacokinetics and Disposition of Biologics
  • Switch from CAR to PXR in the Presence of EGF
  • Alternative P450 Splicing Redirects Human Drug Metabolism
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics